Literature DB >> 543880

Metabolism and kinetics of renal elimination of N-picolyl-3,5-dimethylbenzamides.

P D García de Jalón, E González Fernández, A Idoipe, M R Martínez Larrañaga, M F Braña.   

Abstract

The metabolism and kinetics of renal elimination of N-(2-picolyl)-, N-(3-picolyl)- and N-(4-picolyl)-3,5-dimethylbenzamides were studied. These products have a depressive activity on the central nervous system, as well as an anti-inflammatory and spasmolytic activity. The elimination of the products N-(3-picolyl)- and N-(4-picolyl)-3,5-dimethylbenzamides includes a process of metabolic oxidization of the atom of pyridinic nitrogen with formation of the corresponding N-oxides as main products of its bio-transformation. The process of N-oxidization was not observed with the product N-(2-picolyl)-3,5-dimethyl-benzamide. The results showed that the renal elimination rate of the products studied is greater as the pyridinic nitrogen moves away from the amide group. In the biotransformation process of these products, there is an opposite effect, i.e., the formation of corresponding N-oxides is lower as the pyridinic nitrogen approaches the amide group.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 543880

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  Study of the disposition kinetics of the N-oxide-derivative: a metabolite of picobenzide.

Authors:  D Santos Buelga; E L Mariño; A Domínguez-Gil
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

2.  'In vitro' metabolism of N-picolyl-3,5-dimethylbenzamides.

Authors:  O Caputo; F Viola; G Grosa; F Rocco; G Biglino
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Apr-Jun       Impact factor: 2.441

3.  Isolation and identification of the N-oxide metabolite of picobenzide in human urine.

Authors:  M J Nieto; J M Hernandez Hernandez; J M Lanao; C Fernández; A Domínguez-Gil
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Jan-Mar       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.